Citigroup’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Citigroup’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7	Closed	-$37	–	5920
2023 Q4	$37	Sell	7 -2	-22%	-$12	﹤0.01%	5599
2023 Q3	$71	Hold	9	–	–	﹤0.01%	5485
2023 Q2	$37	Buy	+9	New	+$51	﹤0.01%	5485
2023 Q1	–	Sell	-22	Closed	-$167	–	5436
2022 Q4	$180	Sell	22 -42	-66%	-$822	﹤0.01%	5606
2022 Q3	$2K	Sell	64 -130	-67%	-$4.82K	﹤0.01%	5562
2022 Q2	$8K	Sell	194 -150	-44%	-$11K	﹤0.01%	5469
2022 Q1	$37K	Buy	+344	New	+$53.9K	﹤0.01%	4868

Citigroup's SNCE Position: Q1 2024 in Review

Citigroup sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 7 shares — an estimated $37 sold.

Citigroup first reported a position in SNCE in Q1 2022 and held it in 7 quarters. The position peaked at $37K in Q1 2022. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

Citigroup reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Citigroup sold 7 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $37.
Citigroup first reported a position in Science 37 Holdings, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Citigroup's Science 37 Holdings, Inc. Common Stock position peaked at $37K in Q1 2022.
0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.